Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries

ConditionEmergence Delirium

Trial statusRecruiting

Trial phasePhase 1, Phase 2

Trial typeInterventional

Biological sexAll

Age2-6

SponsorCairo University

About this trial

The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.

Eligibility criteria

Qualifiers

• All pediatric patients aged 2 to 6 years.

Both sexes.

ASA physical status I and II.

Patients undergoing squint surgery.

Disqualifiers

• Refusal of parents.

Patient sensitivity to any of the study medications.

Known neurological disease that can affect the assessment of ED postoperatively.

Trial design

Treatments tested in this trial

Ketamine
Dexmedetomidine

Treatment groups

46 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Cairo University

Lead sponsor

Source ClinicalTrials.gov